<DOC>
	<DOCNO>NCT00349362</DOCNO>
	<brief_summary>The purpose study test effect testosterone treatment glycaemic control , arterial stiffness IMT hypogonadal men type 2 diabetes treat insulin .</brief_summary>
	<brief_title>Testosterone Men With Insulin Treated Type 2 Diabetes</brief_title>
	<detailed_description>There epidemiological data link low serum testosterone level men development diabetes . Clinical trial indicate potential benefit testosterone treatment improve diabetic control insulin resistance . Type 2 diabetes also associate change arterial stiffness IMT know link presence cardiovascular disease . Artificially induced hypogonadism result increase arterial stiffness whilst testosterone know improve risk factor vascular disease act vasodilator . The purpose pilot study test effect six month testosterone replacement , give testosterone ester 200mg Sustanon 250 IM injection , diabetes control hypogonadal men type 2 diabetes treat insulin .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>male 40 year old type 2 diabetes treat insulin serum testosterone less 12nmol/L 2 consecutive morning sample symptom attributable hypogonadism current previous breast cancer current previous prostate cancer raise prostate specific antigen abdominal digital rectal examination suspicious prostate cancer unless diagnosis exclude specialist urology opinion and/or prostate biopsy severe symptom benign prostatic hypertrophy treatment testosterone three month prior trial investigational drug treatment three month prior trial</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>